Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: JCI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on JCI, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 693 JCI shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 693 shares
    Change vs previous 13F -365 shares

    <0.01% of the 13F portfolio, value $101,254.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 1,058 shares
    Change vs previous 13F -690 shares

    <0.01% of the 13F portfolio, value $138,545.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,748 shares
    Change vs previous 13F -718,892 shares

    <0.01% of the 13F portfolio, value $209,339.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 720,640 shares
    Change vs previous 13F -551,132 shares

    1.78% of the 13F portfolio, value $79,240,346.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,271,772 shares
    Change vs previous 13F +138,092 shares

    4.17% of the 13F portfolio, value $134,334,807.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,133,680 shares
    Change vs previous 13F -81,681 shares

    2.84% of the 13F portfolio, value $90,826,392.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,215,361 shares
    Change vs previous 13F +1,215,051 shares

    3.33% of the 13F portfolio, value $95,936,190.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 310 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $24,061.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).